Clinical trial
Effects and Mechanisms of Ocrevus on Ambulatory Functions in People With Relapsing Multiple Sclerosis
NCT04387734 is registered in ClinicalTrials.gov with Georgia State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects and Mechanisms of Ocrevus on Ambulatory Functions in People With Relapsing Multiple Sclerosis
- Lead sponsor
- Georgia State University
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- February 5, 2021
- Completion date
- September 30, 2026
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing multiple sclerosis